Donor eligibility, collections, and inventory—hemovigilance workflows that protect patients and staff.
Safe units, available units—donor journeys and lab holds that match regulatory rigor
We structure donor registration, travel and medication questionnaires, and deferral logic so screeners enforce the same rules at fixed sites and mobile drives. Product inventory tracks components, modifications, and quarantine—releases require documented test completion, not tribal knowledge. Hemovigilance events link to transfusion service feedback—so reaction investigations close loops across hospital interfaces.
01 // THE MANDATE
Donor eligibility, collections, and inventory—hemovigilance workflows that protect patients and staff.
We structure donor registration, travel and medication questionnaires, and deferral logic so screeners enforce the same rules at fixed sites and mobile drives. Product inventory tracks components, modifications, and quarantine—releases require documented test completion, not tribal knowledge.
Hemovigilance events link to transfusion service feedback—so reaction investigations close loops across hospital interfaces.
02 // ENGINEERING
Development process
Structured phases—from discovery to launch—with clear ownership and handoff points.
SOP mapping (weeks 1–6)
MVP (weeks 6–18)
Validation (weeks 14–24)
Go-live (weeks 22–30)
Operate (ongoing)
03 // CAPABILITIES
Core Capability Matrix
The building blocks of your solution
Donors
demographics; deferrals; hemoglobin capture optional.
Screening
questionnaires; digital signatures.
Collections
whole blood; apheresis; lot numbers.
Testing
result imports; NAT; repeat rules.
Components
splits; irradiation; labeling.
Inventory
location; temperature logs optional.
Distribution
hospital orders; emergency release optional.
Compliance
ISBT 128 hooks; audit trail.
Reporting
TTI rates; expiry waste.
API
hospital EMR; courier status optional.
04 // DELIVERY LIFECYCLE
The strategic roadmap
Milestones and checkpoints—each phase has a clear outcome before the next begins.
Weeks 1–6: Requirements with medical director sign-off.
Weeks 7–14: Pilot site paper shadow.
Weeks 15–24: Validation evidence package.
Weeks 25–30: Production reliance.
Ongoing: Accreditation surveys; new products.
05 // PRODUCT SCOPING
Choosing your path
Two engagement models—start lean and iterate, or commit to a full platform build from day one.
MVP
Speed & essentialism
Full product
Enterprise maturity
06 // PARTNERSHIP
Why work together
A single accountable partner across strategy, build, and go-live—not a revolving door of vendors.
End-to-end ownership: discovery, architecture, implementation, and launch—with clear communication and production-grade engineering.
- Discovery & alignment
- Systems that scale
- Implementation depth
- Clear comms
07 // CLARITY
Frequently asked
Workflows mirror your SOPs—validation evidence is co-authored with your QA.
08 // MORE SOLUTIONS
Related solutions
Federated Learning & Privacy-Safe Cross-Silo Analytics Development
Train and aggregate without centralizing raw data—collaborative ML for hospitals, banks, and device fleets.
arrow_forwardAI Agent Orchestration & Multi-Step Workflow Platform Development
Tool use, human approvals, and traces—agents that complete work without silent side effects.
arrow_forwardCrypto Payroll & Global Stablecoin Payments Platform Development
Earnings, tax withholdings, and on-chain settlement—global payouts where compliance and treasury policy stay aligned.
arrow_forwardReady to start?
Tell me about your product goals and timeline—I'll respond with a clear path forward.